The Nutshell Articles | The Scientist Magazine®| Page 291

Most Recent

2007 Nobel: Place your bets!

By Alison McCook | October 5, 2007

We'll all find out who takes this year's Nobel Prizes the morning they do (sometime next week), but there are some early predictions. Thomson Scientific predicts this year's linkurl:Prize for Physiology or Medicine;http://scientific.thomson.com/nobel/med/ will go to linkurl:Fred H. Gage;http://www.the-scientist.com/article/display/12172/ (adult neurogenesis); Joan Massague (action of growth factor beta); and R. John Ellis, F. Ulrich Hartl, and linkurl:Arthur Horwich;http://www.the-scientist.com

1 Comment

Anti-open access group loses another supporter

By Andrea Gawrylewski | October 5, 2007

Another university press has disassociated itself from linkurl:PRISM;http://www.prismcoalition.org/ -- the Partnership for Integrity in Science and Medicine -- an anti-open access advocacy group established by the linkurl:Association of American Publishers;http://www.publishers.org/ (AAP). MIT Press director Ellen Faran resigned from AAP's Professional and Scholarly Publishing Division, The Chronicle of Higher Education linkurl:reported;http://chronicle.com/news/article/3182/anti-open-access-e

0 Comments

Congress admits biosafety gaps

By Alison McCook | October 4, 2007

This in from news editor Alla Katsnelson: At a congressional hearing on linkurl:biosafety;http://www.the-scientist.com/news/display/53626/ today (October 4), the Government Accountability Office reported that the federal government doesn't know how many labs are involved in biosafety level 3 and level 4 work, or where those labs are. Although labs working with certain "select agents" are under the oversight of the CDC, labs working with other pathogens such as SARS or Hantavirus a

0 Comments

Thyroid hormone in utero and vision

By Kerry Grens | October 4, 2007

This morning, at the annual meeting of the linkurl:American Thyroid Association,;http://www.thyroid.org/ann_mtg/2007_78th/index.html I was captivated by a talk that included a very resourceful experimental design. linkurl:Joanne Rovet's;http://www.sickkids.on.ca/RovetLab/default.asp group, at the Hospital for Sick Children in Toronto, described her research on the effects of hypothyroidism in pregnant women on the visual processing of their babies. Rovet's group found that babies exposed to l

0 Comments

Biosafety accidents on the rise

By Alla Katsnelson | October 3, 2007

On the heels of linkurl:recent revelations;http://www.the-scientist.com/news/display/53626/ of unreported accidents in Texas university labs and breaches of safety regulations at the University of Wisconsin, an AP article today linkurl:reports;http://www.washingtonpost.com/wp-dyn/content/article/2007/10/02/AR2007100200158.html on mishaps at biosafety labs across the country. More than 100 such incidents have occurred since 2003, and some were not reported as required, according to the article.

0 Comments

Stem cells to test medicines?

By Alla Katsnelson | October 3, 2007

The British government and three big pharma companies announced a partnership today (October 3) to develop techniques for using linkurl:stem cells;http://www.the-scientist.com/2007/6/1/34/1/ to test the safety of new medicines, the linkurl:Financial Times reports.;http://www.ft.com/cms/s/0/ecdb2c48-714b-11dc-98fc-0000779fd2ac.html So far, the article notes, big companies have stayed away from the controversial field. The group, launched today as a nonprofit called Stem Cells for Safer Medicine

0 Comments

Framingham study data goes online

By Bob Grant | October 2, 2007

The National Institutes of Health has made public more than 50 years worth of data from the linkurl:Framingham Heart Study.;http://www.the-scientist.com/article/display/10377/ The data from that study are the first to go live as part of the recently-launched, web-based SNP Health Association Resource (or SHARe) database, which is funded by NIH's National Heart, Lung, and Blood Institute. As per NIH's recently finalized linkurl:policy;http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088

0 Comments

Biggest losers win pennant

By Richard Gallagher | September 30, 2007

A couple of months ago I linkurl:compared the ineptitude of the Philadelphia Phillies with the pharma industry. ;http://www.the-scientist.com/2007/8/1/13/1/ Well, good news! The Phillies have turned things around. Having picked up the 10,000th loss of their history on 15 July, they today won the National League East title and head to the playoffs for the first time in 14 years. We can all take inspiration from this. I can. The pharmaceutical industry can. There's a lot of talent in the pharma

0 Comments

EHP narrows search for editor

By Bob Grant | September 28, 2007

linkurl:__Environmental Health Perspectives,__;http://www.ehponline.org/ a leading public health journal published by NIH's National Institute of Environmental Health Sciences, will have a new editor-in-chief soon. An NIEHS spokesperson Emailed the list of finalists for the position to __The Scientist__. The three finalists, all of them government employees, are: linkurl:Mike Cunningham -;http://www.f1000biology.com/about/biography/1036539237111759 Toxicologist, National Toxicology Program, NIE

0 Comments

Inspector General: FDA flunking clinical trials oversight

By Alla Katsnelson | September 28, 2007

A linkurl:report;http://www.oig.hhs.gov/oei/reports/oei-01-06-00160.pdf released today by the Department of Health and Human Services reveals that the linkurl:FDA;http://www.the-scientist.com/article/display/36885/ is woefully lax in monitoring clinical trials research, according to the linkurl:New York Times.;http://www.nytimes.com/2007/09/28/health/policy/28fda.html?ref=health The article reports that agency officials don't know how many clinical trials are going, and that just 200 inspecto

0 Comments